Sustainability
Our commitment to environmental sustainability is one of the foundational elements of our corporate culture. In order to continue serving patients, we have to grow in a manner that respects the environment, operate in a transparent and ethical manner, foster sustainable growth, and be a force for positive change around the world.
Commitment to achieving Net Zero
Bristol Myers Squibb is committed to achieving net-zero greenhouse gas emissions across our value chain by 2050, in line with our approved Science Based Targets initiative (SBTi). This commitment is fully supported and adopted by Bristol-Myers Squibb Business Services Limited, Bristol-Myers Squibb Pharmaceuticals Limited, and Celgene Europe Limited (collectively referred to as BMS UK).
In support of the National Health Service’s Net Zero ambition, our Carbon Reduction Plan (CRP) outlines our current GHG emissions, reduction strategies, and key sustainability initiatives.
The information and data presented in the report reflect the global operations of Bristol-Myers Squibb Company, of which BMS UK are wholly owned subsidiaries. The environmental measures described are applicable to BMS UK in the performance of any relevant contracts.
NO-GB-2500082
Date of preparation: June 2025